Diagnostic Accuracy of CT-FFR Compared to Invasive Coronar Angiography With Fractional Flow Reserve

NCT ID: NCT03045601

Last Updated: 2021-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-21

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Invasive coronary angiography is currently considered gold standard in the assessment of coronary artery disease although the method has limitations. Most importantly invasive angiography only depicts coronary anatomy without determining its physiological significance i.e the likelihood that the stenosis impedes oxygen delivery to the heart muscle. Fractional flow reserve (FFR) is a catheterization technique for assessing the physiological significance of a coronary artery lesion during invasive coronary angiography. Coronary computed tomographic angiography (CCTA) is a noninvasive imaging test that has become an alternative route to diagnosis for patients with suspected coronary artery disease. Computational fluid dynamics combined with anatomical models based on CCTA scans allows determination of coronary flow and pressure, and has emerged as a promising diagnostic modality called CT-FFR. In this Project New Mathematical algorithms are developed for computation of CT-FFR. The main objective of this study is to determine the diagnostic accuracy of CT-FFR values obtained by the new method compared with invasive coronary angiography with fractional flow reserve and state-of-the-art dobutamin stress echocardiography.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CT-FFR

Analyse With New CT-FFR Method

Group Type EXPERIMENTAL

CT-FFR

Intervention Type DIAGNOSTIC_TEST

Invasive FFR and CCTA With CT-FFR

Stress echocardiography

Analyse With invasive FFR and stress echocardiography

Group Type ACTIVE_COMPARATOR

Stress echocardiography

Intervention Type DIAGNOSTIC_TEST

Stress echocardiography and invasive FFR

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CT-FFR

Invasive FFR and CCTA With CT-FFR

Intervention Type DIAGNOSTIC_TEST

Stress echocardiography

Stress echocardiography and invasive FFR

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Proven stenosis by CCTA that require further investigation with invasive coronary angiography i.e. patients with estimated stenosis ≥30- 50%.
* Informed consent

Exclusion Criteria

* Patients with unstable coronary artery disease.
* Previously treated with PCI or coronary surgery.
* Severe renal impairment i.e. GFR \<30ml / min
* Contrast allergy
* Contraindication to adenosine / nitroglycerin / beta-blocker
* BMI\> 40
* Patients referred on the basis of technically unsuccessful CTA, motion artifact or similar
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Norwegian University of Science and Technology

OTHER

Sponsor Role collaborator

St. Olavs Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Petter Aadahl, MD, PhD

Role: STUDY_DIRECTOR

Norwegian University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St Olavs Hospital, Klinikk for hjertemedisin

Trondheim, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Braten AT, Fossan FE, Muller LO, Jorgensen A, Stensaeth KH, Hellevik LR, Wiseth R. Automated computed tomography-derived fractional flow reserve model for diagnosing haemodynamically significant coronary artery disease: a prospective validation study. Eur Heart J Imaging Methods Pract. 2024 Sep 30;2(3):qyae102. doi: 10.1093/ehjimp/qyae102. eCollection 2024 Jul.

Reference Type DERIVED
PMID: 39450294 (View on PubMed)

Tjellaug Braten A, Holte E, Wiseth R, Aakhus S. Dobutamine stress echocardiography after positive CCTA: diagnostic performance using fractional flow reserve and instantaneous wave-free ratio as reference standards. Open Heart. 2024 Sep 30;11(2):e002899. doi: 10.1136/openhrt-2024-002899.

Reference Type DERIVED
PMID: 39349050 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016/1609

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OCT Measures Predicting FFR
NCT03573388 COMPLETED